Under physiological conditions, AEP activity is tightly regulated within lysosomes by cystatin C. However, in AD patients, reduced cystatin C levels in cerebrospinal fluid (CSF) and a lowered brain pH result in aberrant AEP activation [[6], [7], [8]]. The gene discussed is LGMN; the disease is Alzheimer disease.